![El Niño‐Southern Oscillation Impacts on Global Wave Climate and Potential Coastal Hazards - Odériz - 2020 - Journal of Geophysical Research: Oceans - Wiley Online Library El Niño‐Southern Oscillation Impacts on Global Wave Climate and Potential Coastal Hazards - Odériz - 2020 - Journal of Geophysical Research: Oceans - Wiley Online Library](https://agupubs.onlinelibrary.wiley.com/cms/asset/5a228d37-ede6-4a65-8348-3c69e2813e4a/jgrc.v125.12.cover.jpg?trick=1696132354883)
El Niño‐Southern Oscillation Impacts on Global Wave Climate and Potential Coastal Hazards - Odériz - 2020 - Journal of Geophysical Research: Oceans - Wiley Online Library
![IJERPH | Free Full-Text | The Postpartum Obsessive-Compulsive Scale: Psychometric, Operative and Epidemiologic Study in a Portuguese Sample IJERPH | Free Full-Text | The Postpartum Obsessive-Compulsive Scale: Psychometric, Operative and Epidemiologic Study in a Portuguese Sample](https://www.mdpi.com/ijerph/ijerph-19-10624/article_deploy/html/images/ijerph-19-10624-g001.png)
IJERPH | Free Full-Text | The Postpartum Obsessive-Compulsive Scale: Psychometric, Operative and Epidemiologic Study in a Portuguese Sample
![Cusatuzumab for treatment of CD70‐positive relapsed or refractory cutaneous T‐cell lymphoma - Leupin - 2022 - Cancer - Wiley Online Library Cusatuzumab for treatment of CD70‐positive relapsed or refractory cutaneous T‐cell lymphoma - Leupin - 2022 - Cancer - Wiley Online Library](https://acsjournals.onlinelibrary.wiley.com/cms/asset/685f2331-36da-4406-80ed-3635a25ec2b8/cncr.v128.5.cover.jpg?trick=1698315852751)
Cusatuzumab for treatment of CD70‐positive relapsed or refractory cutaneous T‐cell lymphoma - Leupin - 2022 - Cancer - Wiley Online Library
![Safety and efficacy of zilucoplan in patients with generalised myasthenia gravis (RAISE): a randomised, double-blind, placebo-controlled, phase 3 study - The Lancet Neurology Safety and efficacy of zilucoplan in patients with generalised myasthenia gravis (RAISE): a randomised, double-blind, placebo-controlled, phase 3 study - The Lancet Neurology](https://www.thelancet.com/cms/asset/3b82ef2b-83bd-444d-a4b5-989bef27023a/gr1.jpg)
Safety and efficacy of zilucoplan in patients with generalised myasthenia gravis (RAISE): a randomised, double-blind, placebo-controlled, phase 3 study - The Lancet Neurology
![Biomonitoring of Perfluoroalkyl Acids in Human Urine and Estimates of Biological Half-Life | Environmental Science & Technology Biomonitoring of Perfluoroalkyl Acids in Human Urine and Estimates of Biological Half-Life | Environmental Science & Technology](https://pubs.acs.org/cms/10.1021/es401905e/asset/images/medium/es-2013-01905e_0003.gif)
Biomonitoring of Perfluoroalkyl Acids in Human Urine and Estimates of Biological Half-Life | Environmental Science & Technology
![Discovery of High-Affinity Ligands of σ1 Receptor, ERG2, and Emopamil Binding Protein by Pharmacophore Modeling and Virtual Screening | Journal of Medicinal Chemistry Discovery of High-Affinity Ligands of σ1 Receptor, ERG2, and Emopamil Binding Protein by Pharmacophore Modeling and Virtual Screening | Journal of Medicinal Chemistry](https://pubs.acs.org/cms/10.1021/jm049073+/asset/images/medium/jm0490731n00001.gif)
Discovery of High-Affinity Ligands of σ1 Receptor, ERG2, and Emopamil Binding Protein by Pharmacophore Modeling and Virtual Screening | Journal of Medicinal Chemistry
![Frontiers | Neanderthal subsistence at Chez-Pinaud Jonzac (Charente-Maritime, France): A kill site dominated by reindeer remains, but with a horse-laden diet? Frontiers | Neanderthal subsistence at Chez-Pinaud Jonzac (Charente-Maritime, France): A kill site dominated by reindeer remains, but with a horse-laden diet?](https://www.frontiersin.org/files/Articles/1085699/fevo-10-1085699-HTML-r1/image_m/fevo-10-1085699-g001.jpg)
Frontiers | Neanderthal subsistence at Chez-Pinaud Jonzac (Charente-Maritime, France): A kill site dominated by reindeer remains, but with a horse-laden diet?
![Safety and efficacy of zilucoplan in patients with generalised myasthenia gravis (RAISE): a randomised, double-blind, placebo-controlled, phase 3 study - The Lancet Neurology Safety and efficacy of zilucoplan in patients with generalised myasthenia gravis (RAISE): a randomised, double-blind, placebo-controlled, phase 3 study - The Lancet Neurology](https://www.thelancet.com/cms/attachment/09a35402-28ee-4a8c-a4a1-d9cea85cacae/gr3.jpg)
Safety and efficacy of zilucoplan in patients with generalised myasthenia gravis (RAISE): a randomised, double-blind, placebo-controlled, phase 3 study - The Lancet Neurology
Kurt De Meyer - Global Product Manager - Hygiene & Healthcare - antimicrobials / biocides - Janssen, Pharmaceutical Companies of Johnson and Johnson | LinkedIn
![Zilucoplan in immune-mediated necrotising myopathy: a phase 2, randomised, double-blind, placebo-controlled, multicentre trial - The Lancet Rheumatology Zilucoplan in immune-mediated necrotising myopathy: a phase 2, randomised, double-blind, placebo-controlled, multicentre trial - The Lancet Rheumatology](https://www.thelancet.com/cms/attachment/74686e29-7d7c-4476-8f0f-e446c41de063/gr1_lrg.jpg)